Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment - Moderate dose Use Study (LiTMUS) for bipolar disorder.

Sylvia, Louisa G; Reilly-Harrington, Noreen A; Leon, Andrew C; Kansky, Christine I; Ketter, Terence A; Calabrese, Joseph R; Thase, Michael E; Bowden, Charles L; Friedman, Edward S; Ostacher, Michael J; Iosifescu, Dan V; Severe, Joanne; Keyes, Michelle; Nierenberg, Andrew A

Sylvia, Louisa G; Reilly-Harrington, Noreen A; Leon, Andrew C; Kansky, Christine I; Ketter, Terence A; Calabrese, Joseph R; Thase, Michael E; Bowden, Charles L; Friedman, Edward S; Ostacher, Michael J; Iosifescu, Dan V; Severe, Joanne; Keyes, Michelle; Nierenberg, Andrew A.

Affiliation

Sylvia LG; Massachusetts General Hospital, Boston, MA 02214, USA. Lsylvia2@partners.org

Clin Trials ; 9(1): 94-101, 2012 Feb.

Article in En | MEDLINE | ID: mdl-22076437

Subject(s)

Bipolar Disorder/drug therapy; Lithium Compounds/therapeutic use; Patient Dropouts/statistics & numerical data; Randomized Controlled Trials as Topic/statistics & numerical data; Humans; Research Design; Single-Blind Method

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Patient Dropouts / Bipolar Disorder / Randomized Controlled Trials as Topic / Lithium Compounds Type of study: Clinical_trials / Guideline / Qualitative_research Limits: Humans Language: En Journal: Clin Trials Journal subject: MEDICINA / TERAPEUTICA Year: 2012 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google